Healthcare
Temasek advances in bid for stake in $2.5b Metro Pacific hospital unit
Temasek advances in bid for stake in $2.5b Metro Pacific hospital unit
This could potentially be the biggest healthcare deal in the Philippines.
IHH Healthcare buys Prince Court Medical Centre for $240m
The deal would give IHH a larger share in the medical tourism market in Klang Valley.
IHH Healthcare profits up 28% to $57.42m in Q2
Singapore and Malaysia’s EBITDA earnings grew 28% and 29%, respectively.
Chinese pharma sales to hit $268b by 2028: Fitch Solutions
The effects of regulatory change on the sales of patented medicine are expected to be mild.
Singapore telehealth firm inks deal with Vietnamese insurer
Bao Minh's customers can consult with a doctor on their phones.
Icon Group acquires Hong Kong oncology clinic SunTech Medical
It is keen to make inroads into the ageing city.
Sumitomo Dainippon Pharma to acquire 10% stake in Roivant for $3b
The pharma will assume ownership interests in five biopharma companies.
Childhood vaccination in Singapore to be subsidised in CHAS general practitioner clinics
Subsidies will available in both polyclinics and CHAS clinics by end-2020.
Singapore medical device output grew 4.2% in June
The industry outperformed the output of the manufacturing sector, which fell 6.9%.
94% of Singapore firms attach international medical plans to healthcare programmes
This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.
VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2
China-based Weimai’s $155m funding round was one of the quarter’s notable deals.
China healthtech funding crashed 49% to $1.92b in H1
The number of deals fell to 62 transactions in the same period.
India's healthtech deal value nearly doubled to $355m in H1
Investments in the wellness category ballooned to $155m.
Singapore clinched $145.78m of healthtech deals in 2018
The city trails only behind China and India in terms of deal value.
Asian healthtech deals hit $2.5b
$595m went to firms geared towards health management solutions.
The chatbot will see you now – virtual HCP engagement in the Asia Pacific
There is little doubt that the Asia Pacific region represents a key growth ambition for the majority of Life Sciences companies. Statistics around...
Cell therapy in the Asia Pacific — solution to the cancer challenge?
Over the next decade, an estimated $2t investment into Universal Health Coverage (UHC) schemes is expected to land in Asia. The developing markets in...
Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Event News
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
